SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Piramal Healthcare invests 2 million pounds in Scottish plant

18 Nov 2015 Evaluate

In a bid to expand its manufacturing plant in Scotland, Piramal Healthcare has invested two million pounds. The company is aiming to expand this facility in the next 5 years to maintain its position as a global leader in the production of antibody drug conjugates.

The plant manufactures anti-cancer drugs (antibody drug conjugates) for export. The investment of two million pounds into Scotland will yield additional revenue of 3-5 million pounds over five years to Piramal Healthcare’s revenue.

Piramal Enterprises is one of India’s large diversified companies, with a presence in Healthcare, Healthcare Information Management and Financial Services. Its consolidated revenues were over $830 million in FY2015, with approx. 70% of revenues from outside India.

Piramal Ent - Amalga Share Price

1124.60 0.00 (0.00%)
22-Sep-2025 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×